International Prognostic Index (IPI)

Aggressive non-Hodgkin lymphoma prognosis — 5 adverse factors, 0 to 5
Age > 60 years
Serum LDH above the upper limit of normal
ECOG performance status ≥ 2
Ann Arbor stage III or IV
More than one extranodal site

About this score

When to use

A prognostic model for aggressive non-Hodgkin lymphoma from five pretreatment factors: age over 60, raised LDH, ECOG 2 or more, Ann Arbor III–IV and more than one extranodal site. ⁦[1]⁩

Pearls and pitfalls

• Four risk groups had 5-year overall survival of 73%, 51%, 43% and 26%. ⁦[1]⁩
• In diffuse large B-cell lymphoma treated with R-CHOP, the revised IPI regroups the score into very good (0), good (1–2) and poor (3–5), with 4-year progression-free survival of 94%, 80% and 53%. ⁦[2]⁩
Summarised from the numbered sources under Evidence. Check the source before relying on a statement.
Evidence
[1] Original publication
The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. Five pretreatment factors (age > 60, raised LDH, ECOG ≥ 2, Ann Arbor III–IV, > 1 extranodal site) defined four risk groups with 5-year overall survival of 73%, 51%, 43% and 26%.
New England Journal of Medicine, 1993
Open source
[2] Validation
Sehn LH, Berry B, Chhanabhai M, et al. The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. Regroups the score into very good (0), good (1–2) and poor (3–5), with 4-year progression-free survival of 94%, 80% and 53%.
Blood, 2007
Open source
Last reviewed: 2026-10
Report an error in this calculator
MedScore is an educational and clinical decision-support tool. It does not provide a diagnosis, a treatment, or a drug-dosing recommendation, and it does not replace clinical judgement or local guidelines. Confirm every result against the original source before acting on it. The treating clinician remains responsible for all decisions.
Support the developer
MedScore is free on the web and made by a medical student. If it helps you, you can support its development.
Support MedScore